Access in-depth financial reports, earnings summaries, and data-driven insights. We break down company results, market outlooks, and research-backed analysis. Understand the numbers behind the news.
Ideal for serious investors and curious minds alike.

Eli Lilly Q1 2025 Earnings: Mounjaro, Zepbound Push Revenue to Record $12.7 Billion Amid Strong Pipeline Momentum

Eli Lilly and Company (NYSE: LLY) delivered a blockbuster first quarter for fiscal 2025, fueled by the surging success of its diabetes and obesity treatments—Mounjaro and Zepbound—and further bolstered by…

Continue ReadingEli Lilly Q1 2025 Earnings: Mounjaro, Zepbound Push Revenue to Record $12.7 Billion Amid Strong Pipeline Momentum

India’s Silent Health Crisis: NCDs Rising Even Among Youth, Reveals Apollo’s 2025 Report

As India celebrated World Health Day on April 7, Apollo Hospitals released its landmark “Health of the Nation 2025” report, revealing alarming trends in the country's health landscape. The report,…

Continue ReadingIndia’s Silent Health Crisis: NCDs Rising Even Among Youth, Reveals Apollo’s 2025 Report